Risteys · L12_ERYTHINOTH

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L54* Cause of death: ICD-10 — L54* 2 out of 7 registries used, show all original rules.	74
4. Check minimum number of events None	74
5. Include endpoints None	74
6. Filter based on genotype QC (FinnGen only)	74

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	461	302	158
Only index persons	439	286	153
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.00
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	56.68	58.12	53.91
Only index persons	56.26	57.79	53.42

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	74	49	25
Unadjusted period prevalence (%)	0.01	0.02	0.01
Median age at first event (years)	54.10	51.01	60.16

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
68: Matched controls
681

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L548, A692

ICD-10 Finland

+∞

43.5

A69.2

ICD-10 Finland

Lyme disease

27.0

20.1

L54.8

ICD-10 Finland

Erythema in other diseases classified elsewhere

+∞

17.4

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

7.1

8.6

L54.0*I00

ICD-10 Finland

Erythema marginatum in acute rheumatic fever

+∞

8.5

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(40761535) Cells panel - Urine sediment

4.33

6.75

5.2

2.9

—

(3013707) Erythrocyte sedimentation rate by Westergren method

487

4.28

4.91

5.9

4.3

mm/h

11.1

12.0

0.27

443

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

4.99

4.74

1.2

1.6

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

629

+∞

4.69

18.1

13.5

mg/l

17.6

21.1

0.59

494

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

3.10

4.05

11.1

7.9

—

(3020891) Body temperature

4.13

3.48

7.6

5.2

—

(40758558) Short blood count panel - Blood

166

2.36

3.06

8.6

6.9

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

4.50

2.99

2.7

1.4

g/l

1.1

1.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

137

2.38

2.94

7.0

3.2

—

(36304419) Bacteria [Presence] in Urine

160

2.21

2.58

3.1

2.9

—

(3001604) Monocytes [#/volume] in Blood

321

2.14

2.53

8.8

5.5

e9/l

0.6

0.41

285

(40768443) Skin Pathology biopsy report

3.95

2.44

1.4

1.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2.36

2.23

3.6

2.0

31.6

28.9

0.53

(3000991) Gas panel - Venous blood

2.83

2.21

4.6

6.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

235

1.93

2.00

6.3

4.2

—

(3035350) Ketones [Presence] in Urine by Test strip

300

1.93

1.99

5.9

3.9

estimate

0.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

4.79

1.97

1.6

1.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

301

1.91

1.96

7.3

5.5

estimate

0.0

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

511

2.32

1.92

10.1

7.1

u/l

76.1

77.8

0.18

474

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

594

2.78

1.92

4.7

5.1

mu/l

2.0

1.9

0.26

541

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2.34

1.91

2.5

2.0

nmol/l

366.6

379.1

0.10

(3030467) Casts [#/volume] in Urine by Automated count

170

1.93

1.84

3.6

3.2

e6/l

0.2

0.3

0.60

129

(3029937) Albumin [Presence] in Urine by Test strip

158

1.88

1.66

6.8

3.8

estimate

0.0

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

118

1.95

1.62

1.2

1.3

iu/ml

12.8

55.3

—

(3000494) Fungus identified in Specimen by Culture

2.16

1.62

1.1

1.5

—

(3018095) Leukocytes [#/volume] in Urine

222

1.78

1.57

3.9

3.4

e6/l

16.7

53.5

0.82

158

(3002582) Erythrocytes [#/volume] in Urine

187

1.80

1.56

3.9

3.1

e6/l

10.7

46.3

1.13

147

(3031040) Bacteria [#/volume] in Urine by Automated count

407

1.81

1.53

5.6

3.9

—

36.6

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

121

1.89

1.50

1.3

1.2

u/ml

14.4

10.7

—

(3044640) Blood type and Crossmatch panel - Blood

180

1.79

1.50

2.6

2.2

—

(3007853) Bacteria identified in Skin by Aerobe culture

2.19

1.48

1.9

1.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.19

1.48

1.7

1.6

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2.42

1.46

2.6

3.2

0.7

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

3.27

1.46

1.6

1.3

—

(3019060) Gas panel - Arterial blood

2.36

1.43

7.9

4.4

—

(42870588) Differential panel, method unspecified - Blood

201

1.73

1.40

8.1

4.9

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

284

1.69

1.40

4.8

3.7

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2.30

1.39

2.6

3.1

1.3

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2.24

1.36

3.3

2.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

203

1.70

1.34

3.7

3.2

mmol/l

2.4

0.21

177

(3045414) Leukocytes [Presence] in Urine

2.63

1.33

3.5

1.8

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

250

1.67

1.31

5.2

3.7

ng/l

20.0

34.0

0.80

171

(3032080) INR in Blood by Coagulation assay

250

1.67

1.31

12.5

7.4

inr

1.3

1.1

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

2.74

1.23

1.0

1.2

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2.24

1.23

1.6

1.4

—

(3012544) pH of Venous blood

2.01

1.22

2.3

3.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

130

1.74

1.19

3.1

2.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.86

1.18

2.2

1.7

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

2.60

1.17

1.0

1.3

—

3.7

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

2.60

1.17

1.0

1.3

—

1.9

—

(3023368) Bacteria identified in Blood by Culture

165

1.67

1.17

3.2

4.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.92

1.15

1.6

1.4

—

(3026008) Bacteria identified in Urine by Culture

184

1.64

1.13

4.3

3.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

505

1.69

1.02

4.4

4.2

pmol/l

15.2

14.8

0.35

457

(46235355) HIV 1 and 2 tests - Meaningful Use set

1.77

0.99

1.2

1.5

—

(1002224) Polysomnography panel

0.00

0.99

0.0

1.2

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2.24

0.94

8.8

6.6

mmol/l

24.4

25.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.84

0.92

2.2

1.7

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1.71

0.89

3.9

4.4

28.9

33.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

106

0.53

0.80

1.5

1.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

572

1.68

0.80

15.3

14.5

37.6

39.7

0.49

400

(3037467) Urinalysis macro (dipstick) panel - Urine

422

1.48

0.79

6.3

4.2

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

180

1.49

0.79

4.1

2.9

ng/l

845.4

884.2

0.04

154

(40768804) Tissue Pathology biopsy report

255

1.45

0.78

1.7

2.0

—

(4034850)

1.99

0.72

19.0

13.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

156

1.48

0.72

7.7

5.0

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1.58

0.70

2.8

2.7

mmol/l

0.8

0.69

(1761868) Lipid panel - Serum or Plasma

250

0.68

0.70

1.9

3.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1.71

0.62

1.0

1.8

u/l

44.2

36.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.71

0.62

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

0.00

0.61

0.0

1.2

—

(40768793) Breast Pathology biopsy report

0.00

0.61

0.0

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.62

0.59

1.7

1.4

—

(3019309) Folate [Moles/volume] in Red Blood Cells

108

1.49

0.59

2.3

1.7

nmol/l

2377.7

1182.5

—

(3042936) Bacteria identified in Isolate by Culture

1.57

0.57

2.7

2.2

—

(3000330) Specific gravity of Urine by Test strip

1.68

0.57

5.7

—

(3021589) Normoblasts [#/volume] in Blood

296

1.35

0.56

8.8

9.7

e9/l

0.0

0.50

250

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

614

1.48

0.48

7.3

6.0

mmol/mol

41.8

40.4

0.44

572

(3022621) pH of Urine by Test strip

1.51

0.48

5.7

2.7

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1.50

0.44

2.4

3.1

umol/l

6.1

8.2

—

(3019225) pH of Specimen

1.40

0.42

9.0

3.5

—

(3003694) ABO and Rh group [Type] in Blood

162

1.32

0.41

1.4

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.4

—

46.9

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

0.00

0.39

0.0

1.0

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.50

0.37

1.2

1.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.50

0.37

1.3

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1.38

0.36

2.3

1.4

—

(40761536) Microorganisms panel - Urine sediment

1.43

0.36

2.3

3.5

—

(3012516) Albumin [Mass/volume] in Urine

194

1.27

0.35

3.8

3.1

mg/l

17.8

52.8

1.39

135

(3002256) Pathology report gross observation

1.41

0.34

1.3

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

642

1.46

0.33

5.7

4.7

mmol/l

4.9

4.7

0.75

589

(3013512) EKG study

207

1.24

0.30

3.8

4.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1.33

0.30

4.8

2.9

e6/l

1.5

4.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

181

1.22

0.26

4.9

5.1

ug/l

3.8

1.7

1.00

158

(3022145) Colonoscopy Study observation

0.72

0.25

1.3

1.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

156

0.80

0.24

1.5

1.6

nmol/l

33.1

20.8

0.81

133

(3019832) Treponema pallidum Ab [Presence] in Serum

1.38

0.24

1.2

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.34

0.24

1.2

1.0

—

(3009508) Creatinine [Moles/volume] in Urine

203

1.19

0.23

3.6

2.9

mmol/l

7.3

7.7

0.12

175

(3028026) IgM [Mass/volume] in Serum or Plasma

1.24

0.22

1.4

g/l

1.5

1.0

—

(3025130) Human papilloma virus identified in Specimen

0.00

0.21

0.0

2.5

—

(3011288) Drugs identified in Urine by Screen method

0.00

0.21

0.0

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

0.21

0.0

4.5

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

0.21

0.0

2.0

—

(3028707) Methadone [Presence] in Urine by Screen method

0.00

0.21

0.0

1.2

—

(3023410) Appearance of Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

0.00

0.21

0.0

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.21

0.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.21

0.0

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

0.00

0.21

0.0

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

0.00

0.21

0.0

1.2

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

3.5

—

15.8

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

618

1.26

0.21

5.2

4.1

mmol/l

1.4

1.3

0.97

563

(44816559) Phosphatidylethanol [Mass/volume] in Blood

0.00

0.20

0.0

1.1

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.20

0.0

1.6

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.20

0.0

1.6

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

364

1.15

0.19

2.8

2.7

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1.23

0.19

1.9

2.2

g/l

0.3

0.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1.22

0.17

1.4

4.1

ug/l

2.4

7.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

169

1.17

0.17

3.2

4.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

209

1.15

0.15

4.1

3.9

mg/mmol

11.1

7.8

0.14

139

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1.16

0.09

2.5

2.4

g/l

2.3

2.4

0.12

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

254

1.10

0.09

1.6

2.0

pmol/l

90.3

98.4

0.45

131

(3044889) 12 lead EKG panel

456

0.91

0.09

4.6

3.8

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.12

0.09

1.5

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.07

0.08

2.3

3.3

—

(40768797) Stomach Pathology biopsy report

1.07

0.08

1.1

1.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

657

1.21

0.07

6.4

5.2

mmol/l

3.0

2.8

1.09

601

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

640

1.13

0.07

5.9

4.7

mmol/l

1.5

0.02

586

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

193

1.05

0.01

1.5

1.7

mmol/l

1.6

1.3

0.64

159

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

137

1.03

0.00

3.3

4.4

18.0

20.9

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

146

1.03

0.00

1.3

1.2

u/ml

0.5

2.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.00

0.00

1.5

1.7

—

(3023520) Reticulocytes [#/volume] in Blood

1.00

0.00

8.0

2.8

e9/l

115.3

71.6

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.00

0.0

1.0

—

(4268621)

0.00

0.0

1.7

—

(3051611) Lipemic interference index of Serum or Plasma

0.00

0.0

2.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.00

0.0

5.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

0.0

1.0

—

(4027681)

0.00

0.0

1.1

—

(40768441) Liver Pathology biopsy report

0.00

0.0

1.0

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

0.00

0.0

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.1

—

(4035726)

0.89

0.00

1.4

—

(3000012) Reticulocyte production index

0.00

0.0

1.0

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

0.00

0.0

1.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

0.0

1.3

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

0.00

0.0

1.0

—

5.7

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

0.0

1.9

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.0

2.4

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

0.0

1.6

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

0.0

1.7

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.00

0.0

1.7

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

0.0

15.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

0.00

0.0

1.2

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

0.0

19.2

—

921.6

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

0.0

1.6

—

(3005033) Fetal Nuchal fold Thickness US

0.00

0.0

1.7

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

0.0

1.0

—

88.8

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

0.00

0.0

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

0.0

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

0.0

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

0.00

0.0

2.7

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.0

1.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

0.0

1.6

—

0.9

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.00

0.0

1.0

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.3

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

0.00

0.0

6.7

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.00

0.0

1.0

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.00

0.0

1.7

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

0.0

25.4

—

1306.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.0

2.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

0.00

0.0

2.7

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

0.0

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

1.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

0.00

0.0

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.00

0.0

1.9

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

0.0

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.00

0.0

1.7

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

0.00

0.0

1.5

—

(21494434) Karyotype in Bone marrow

0.00

0.0

1.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

0.00

0.0

1.7

—

(4146454)

0.00

0.0

2.9

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

0.00

0.0

1.2

—

33.4

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_ERYTHINOTH and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have L12_ERYTHINOTH.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: L12_ERYTHINOTH – Erythema in diseases classified elsewhere

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

NAME	L12_ERYTHINOTH
CONTROL_EXCLUDE	L12_URTICARIAERYTHEMA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L54
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L54
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Erythema in diseases classified elsewhere

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints